Evaluating the therapeutic potential of CRISPR/Cas9 based gene editing in a newly developed inducible multi-systemic myotonic dystrophy mouse model

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)44-45
Number of pages2
JournalHuman Gene Therapy
Issue number3-4
Publication statusPublished - Feb 2024
Event30thEuropean Society of Gene and Cell Therapy (ESGCT) Annual Congress, in collaboration with SFTCG and NVGCT - Brussels, Belgium
Duration: 24 Oct 202327 Feb 2024

Cite this